Zdrowie i gospodarka · 02/08/2018

FDA Revokes Authorization for Ebola Virus Test

The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for the ReEBOV Antigen Rapid Test, issued to Zalgen Labs, LLC, due to a request from the company itself, effective May 18, 2018.